logo
Share SHARE
FONT-SIZE Plus   Neg

Abbott Labs Announces CE Mark For Testosterone Test - Quick Facts

Abbott Laboratories (ABT) announced CE Marking or Conformite Europeenne for a testosterone assay with improved sensitivity and clinical utility. The company noted that ARCHITECT 2nd Generation Testosterone Assay can accurately measure the wide range of testosterone levels seen in a number of different patient populations and clinical settings.

Testosterone assays play an important role in the diagnosis and management of many medical conditions in men, women, and children.

The company stated that the new assay runs on its fully-automated ARCHITECT family of analyzers and is available in several European countries, Asia Pacific, Latin America, Japan, Africa, Middle East, and India, pending country registration.

The ARCHITECT 2nd Generation Testosterone Assay is a chemiluminescent microparticle immunoassay for the quantitative determination of testosterone in human serum and plasma.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Gold rallied Thursday morning as presumptive GOP nominee Donald Trump proclaimed himself a "low interest rate person" who would push for new leadership at the Federal Reserve. Trump said he would not reappoint current Fed Chair Janet Yellen, who happens to be one of the architects of the Fed's current... Merck & Co. Inc.(MRK) reported a profit for the first-quarter that grew 18 percent from the prior year, while quarterly sales declined 1 percent. Adjusted earnings per share topped analysts' expectations, while quarterly sales missed their estimates. Shares of WM Morrison Supermarkets Plc were gaining more than 4 percent in the early Thursday morning trading as it reported 0.7 percent increase in first-quarter like-for-like sales excluding fuel. LFL sales were up 1.2 percent, including fuel.
comments powered by Disqus
Follow RTT